Sofinnova
Paul Chang

Paul Chang

Analyst, Public Equity

Paul joined Sofinnova BioEquities in 2025 as an Analyst. He focuses on public investments in medical technology and diagnostics. 

Before joining Sofinnova, Paul worked as an Investment Associate at TPG Growth, identifying new healthcare investments and providing operational support for portfolio companies. Before TPG, Paul was an Investment Banker at Goldman Sachs where he focused on healthcare M&A and financing.

Paul received his BS in Finance with a minor in English Literature from New York University.